Octreotide-induced hypoxemia and pulmonary hypertension in premature neonates

Journal of Pediatric Surgery

Volumn 38, Issue 2, 2003, Pages 251-253

  Arevalo, R P ^a   Bullabh, P ^a   Krauss, Alfred Nathaniel ^a   Auld, P A M ^a   Spigland, Nitsana ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Enterocutaneous fistula; Pulmonary hypertension; Somatostatin

Indexed keywords

INDOMETACIN; LUNG SURFACTANT EXTRACT; OCTREOTIDE; SOMATOSTATIN DERIVATIVE;

ARTICLE; CASE REPORT; ENTEROCUTANEOUS FISTULA; HIGH RISK PATIENT; HUMAN; MALE; NECROTIZING ENTEROCOLITIS; NEWBORN; NEWBORN HYPOXIA; PREMATURITY; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RESPIRATORY DISTRESS;

EID: 0037308790     PISSN: 00223468     EISSN: None     Source Type: Journal    
DOI: 10.1053/jpsu.2003.50056     Document Type: Article

References (16)

1. Lamberts SW: A guide to the clinical use of the somatostatin analogue SMS 201-995 (Sandostatin). Acta Endo Suppl 286:54-66, 1987
2. Mosdell KW, Visconti JA: Emerging indications for octreotide therapy Part I. Am J Hosp Pharm 51:1184-1192, 1994
3. Mosdell KW. Visconti JA: Emerging indications for octreotide therapy Part II, Am J Hosp Pharm. 51:1317-1330, 1994
4. Katz MD, Erstad BL: Octreotide, a new somatostatin analogue. Clin Pharm 8:255-273, 1989
5. Sancho J, Di Costanzo J, Nubiola P. et al: Randomized double-blind placebo-controlled trial of early octreotide in patients with postoperative enterocutaneous fistula. Br J Surg 82:638-641, 1995
6. Wallace AM, Newman K: Successful closure of intestinal fistulae in an infant using somatostatin analogue SMS 201-995. J Pediatr Surg 26:1097-1100, 1991
7. Torres AJ, Landa JIM, Moreno-Azcoita M, et al: Somatostatin for enterocutaneous fistula: A silver bullet? Arch Surg 127:97-100, 1992
8. Lin HC, Hou MC, Lee WC. et al: Effects of octreotide on central hemodynamics and systemic oxygen use in patients with viral cirrhosis. Am J Gastroenterol 94:1012-1016, 1999
9. Torrecillas G. Medina J, Diez-Marques ML, et al: Machanisms involved in the somatostatin-induced contraction of vascular smooth muscle cells. Peptides 20:929-935, 1999
10. Raynor K, O'Carroll AM, Kong H, et al: Characterization of cloned somatostatin receptors SSTR4 and SSTR5 Mol Pharm 44:385-392, 1993
11. Sodermann C, Anders JD, Lars L, et al: Ventilation-perfusion relationships and central hemodynamics in patients with cirrhosis. J Hepatol 21:52-57, 1994
12. Evans NJ, Archer LN: Doppler assessment of pulmonary artery pressure during the recovery from hyaline membrane disease. Arch Dis Child 66:802-804, 1991. (7 Spec No)
13. Greenspan JS, Abassi S, Bhutani VK: Sequential changes in pulmonary mechanics in the very low birth weight (less than or equal to 1000 grams) infants. J Pediatr 113:644-650, 1988
14. Gratz I: Pulmonary hypertension. Anes Clin North Am 17:693-707, 1999
15. Glasser B, Hirsch HJ, Landau H: Persistent hyperinsulinemic hypoglycemia of infancy: Long term octreotide treatment without pancreatectomy. J Pediatr 123:644-650, 1993
16. Scheidermaier P, Brensing KA, Goke B, et al: Effects of different octreotide dosages on splanchnic hemodynamics. and glucagon in healthy volunteers. Digestion 60:132-140, 1999